Koichiro Yoshino

4PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 27, 2026
High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer.

|Nov 06, 2023
Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study.

Keitaro Shimozaki, Izuma Nakayama, Daisuke Takahari

|Jul 06, 2023
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors.

Koshiro Fukuda, Hiroki Osumi, Koichiro Yoshino

|Aug 16, 2022
Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.

Koichiro Yoshino, Hiroki Osumi, Hiromichi Ito

Pageof 1

Frequent Collaborators

3 joint publications

Hiroki Osumi

3 joint publications

Shota Fukuoka

3 joint publications

Mariko Ogura

3 joint publications

Takeru Wakatsuki